Frontlight ResearchEarly access
Active, not recruitingNo phase
Assessment of DOT Spectacles in Chinese Children
Key facts
- Who runs it
- SightGlass Vision, Inc.
- Where
- China5 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 195 people enrolled
- Started
- 5 Feb 2023
- Expected to end
- 31 Dec 2027
- Type of study
- Interventional, 2 groups
- Treatments tested
- Novel spectacle lens design
- Spectacle lenses
- Record updated
- 13 July 2026
Who can take part
- Age
- 6 years to 13 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- Children 6-13 years of age
- SER error between -0.75D and -5.00D
- Willingness to wear study spectacles and participate in the trial for 12 months without contact lens wear
Who cannot take part
- Prior usage of atropine, multifocal contact lenses, or orthokeratology (ortho-K)
- Astigmatism worse than -1.50 DC (by manifest refraction) in either eye
- Anisometropia (SER manifest refraction) greater than 1.00 D
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This is a randomized, controlled, evaluator-blinded, multicenter, two-arm parallel group clinical trial to evaluate the continued safety and efficacy of Diffusion Optics Technology (DOT) spectacle lenses by comparing to single vision, impact-resistant spectacle lenses in reducing the progression of myopia in children of Chinese origin.
The 2 groups in the trial
- SightGlass Vision Test Arm 1Treatment being tested
Single vision, impact-resistant spectacle lenses
Treatment: Novel spectacle lens design
- Test Arm 2Other group
Single vision, impact-resistant spectacle lenses
Treatment: Spectacle lenses
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Clinical Assessment of DOT Spectacle Lenses in Chinese Children
- Record updated
- 13 July 2026